Dynamic contrast-enhanced magnetic resonance imaging in oncology

Topics in Magnetic Resonance Imaging

Volumn 12, Issue 4, 2001, Pages 301-308

  Knopp, Michael V ^a   Giesel, Frederik L ^a   Marcos, Hani ^a   Von Tengg Kobligk, Hendrik ^a   Choyke, Peter ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Angiogenesis; Dynamic contrast enhanced magnetic resonance; Oncologic imaging; Therapy monitoring

Indexed keywords

GADOLINIUM CHELATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PRIORITY JOURNAL; REVIEW;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0034765047     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200108000-00006     Document Type: Review

References (30)

1. MR microcirculation assessment in cervical cancer: Correlations with histomorphological tumor markers and clinical outcome
2. Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma
3. MR imaging of tumor microcirculation: Promise for the new millennium
4. Assessment of tumor microcirculation: A new role of dynamic contrast MR imaging
5. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
6. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
7. Pediatric musculoskeletal tumors: Use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy
8. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging
9. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy
10. Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors
11. Primary bone tumors: Value of MR angiography for preoperative planning and monitoring response to chemotherapy
12. Angiogenesis in cancer and other diseases
13. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions
14. Pathophysiologic basis of contrast enhancement in breast tumors
15. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors
16. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features
17. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
18. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography
19. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats
20. Key factors in the acquisition of contrast kinetic data for oncology
21. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols
22. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents
23. A review of contrast media research in 1999-2000
24. Contrast agents for MRA: Future directions
25. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: Status report
26. Pelvic lesions in patients with treated cervical carcinoma: Efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions
27. Ewing's sarcoma recurrence vs radiation necrosis in dynamic contrast-enhanced MR imaging: A case report
28. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma
29. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: Pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy
30. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: Preliminary results and implications for therapy